Exchange: NASDAQ·Updated 07:59 PM EST
CAPR logo

CAPR Capricor Therapeutics Inc

$10.24
$0.98
(8.73%)
Today
Closed $10.24
$0.22
(2.15%)
After Hours
Reported EarningsNov 10
Mkt Cap$652.35M
Vol4.78M

About CAPR

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
76

Extremely Bullish Sentiment

How do you feel about CAPR?

Dash_Man
$CAPR To state the obvious, nothing is guaranteed. But... CAPR’s reported institutional holdings currently total approximately 43.7 million shares, or 82% of its 53.2 million-share float. With remaining third-quarter 13Fs due Monday, that figure could conceivably rise to 47 million shares (88% of float) if the purchase to sale ratio of reported 13F's for the current quarter holds the same pattern for the unreported. Meanwhile, 158,372 outstanding call contracts represent approximately 6.65 million shares of gross delta exposure, assuming a 0.42 average delta. If market makers hold even half that exposure as stock hedges, another 3.3 million shares could be accounted for. Assuming no overlap, that puts institutional and dealer holdings at 88–95% of the float, alongside short interest exceeding 35%.
30
Stormfury66
$CAPR Still so undervalued.. WOW the squeeze will be astronomical.. Should already be trading at at least 15-20.... Squeeze 40-50+ Linda is in discussions about the label.. Holding 147K worth of shares.. Should be a great holiday for all!
23
dnfrs
$CAPR In life a lot of things come down to "Who do you trust?" On one hand we have... * Peer reviewed LANCET article * Amazing ROBUSTNESS analysis * Letter from 28 DMD experts * American Heart Association Award * Testimony from dozens of DMD families On the other hand we have... * The phoney Adcomm which was based on an illegal SAP, had no DMD experts on the Panel, Refused to allow a rebuttal of their obvious confusion, Refused to consider the Peer reviewed Lancet article, and Refused to consider the powerful real life testimony of the DMD families. I know who I trust !
20
erpy
$CAPR Your leader!! Articulate, smart, beautiful, hard working, dedicated to the cause. You decide !!!
1
17
noviceEve
$CAPR Drop this dropper and buy $SLS tomorrow. Up 20% after hours. Ceo confirmed data this month.
18
Chachi88
$CAPR Stop loss hunting again this am…don’t lose your shares when $40+ is on the table post approval.
19
SilentSniper
$CAPR 6. The July briefing doc Every FDA quote in the short article comes from the July briefing document. That was written before the amendment. The two-year OLE data and the robustness analyses weren't in it. FDA then chose to accept those as a major amendment and review them for three more months. Quoting July as the final word skips the part of the review that's still open.
17
Zyntax
$CAPR If the whole us market is down just because jensen banged chinese woman then I am actually blown away of stupidity of this market.
17
Millie_Seconds
$CAPR Trump fired Susie Willies who was micromanaging the different agencies and her lobby firm was taking money from BP. This bodes well for CAPR
16
Carnagex
$CAPR is 10 days away from PDUFA. $SLS is 15 days since 80th event. We will have answers very soon!! 🚀🚀😊
16
StrategySuccess
$CAPR The upper-limb focus is what matters to me. For DMD, meaningful functional improvement is not some little footnote.
16
WBinthehouse
$CAPR hit job articles gonna come with PDUFA next week. Hang tight they are getting petrified with the current run
15
erpy
$CAPR Same thing everyday. Hopefully everyone knows this drill. One thing they can't predict is when news. Why it matters? Sit back relax grab your favorite snack ! Lfg!!!
15
mrgupo
$CAPR i reaffirm, this is still cheap! +50$ should be all our targets! Don’t sell for cheapies!
15
WBinthehouse
$CAPR seeking alpha wrote this “For now, remember that HOPE-3 was powered to detect a 1.5-point difference in the PUL 2.0 total score change from baseline to Month 12, and a 1.0-point change [in this timeframe] represents a “clinically relevant” or “clinically meaningful” benefit.” Nope it’s not 1.5 it’s 1.1 point difference in the PUL 2.0 total score. Seeking Alpha again is caught lying lol
14
pasu4
$CAPR I’ve never believed a word from anything Seeking Alpha has to say. We’ll see what happens! 🚀🚀
1
11
satrasal
$CAPR 2 seekingalpha articles trying to tank the stock. To be expected. Using sap 1.1 and shukla's abuse of process, and since fda has not published that they will be using a different sap, these articles get to say what they find in the briefing book. That book doesn't have John Scotts assertion that sap 3.0 contins the prespecified endpoints. So pick up cheapies while we can. I got some dec 5 calls and an dec 15/30 spread which should outperform cap stock upto price 55.
14
Carnagex
$CAPR The way I look at it. We have 6 more business days before a FDA decision is known. There will be some that are set in their positions and some that aren’t. Either way, the clock is ticking. Many shorts will exit this Friday imo.
13
Tamalecowboy
$CAPR lol down 2% n shorts are out jerking themselves off after a fat run up. Pathetic losers 🤡
14
StockDZL
$CAPR look at the 5yr chart, left shoulder and head have completely formed. Right shoulder is in process of forming. $20 easy on its way.
14

Advertisement|Remove ads.